A citation-based method for searching scientific literature

Jason Gotlib, Julia E Maxson, Tracy I George, Jeffrey W Tyner. Blood 2013
Times Cited: 107







List of co-cited articles
718 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
Julia E Maxson, Jason Gotlib, Daniel A Pollyea, Angela G Fleischman, Anupriya Agarwal, Christopher A Eide, Daniel Bottomly, Beth Wilmot, Shannon K McWeeney, Cristina E Tognon,[...]. N Engl J Med 2013
319
78

CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
A Pardanani, T L Lasho, R R Laborde, M Elliott, C A Hanson, R A Knudson, R P Ketterling, J E Maxson, J W Tyner, A Tefferi. Leukemia 2013
158
55

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
Rocco Piazza, Simona Valletta, Nils Winkelmann, Sara Redaelli, Roberta Spinelli, Alessandra Pirola, Laura Antolini, Luca Mologni, Carla Donadoni, Elli Papaemmanuil,[...]. Nat Genet 2013
242
46

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
43

Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
Sa A Wang, Robert P Hasserjian, Patricia S Fox, Heesun J Rogers, Julia T Geyer, Devon Chabot-Richards, Elizabeth Weinzierl, Joseph Hatem, Jesse Jaso, Rashmi Kanagal-Shamanna,[...]. Blood 2014
109
41

Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia.
Kim-Hien T Dao, Magdolna B Solti, Julia E Maxson, Elliott F Winton, Richard D Press, Brian J Druker, Jeffrey W Tyner. Leuk Res Rep 2014
54
57

Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.
Manja Meggendorfer, Torsten Haferlach, Tamara Alpermann, Sabine Jeromin, Claudia Haferlach, Wolfgang Kern, Susanne Schnittger. Haematologica 2014
57
50

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
M Meggendorfer, U Bacher, T Alpermann, C Haferlach, W Kern, C Gambacorti-Passerini, T Haferlach, S Schnittger. Leukemia 2013
112
28

The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.
Angela G Fleischman, Julia E Maxson, Samuel B Luty, Anupriya Agarwal, Lacey R Royer, Melissa L Abel, Jason D MacManiman, Marc M Loriaux, Brian J Druker, Jeffrey W Tyner. Blood 2013
69
40

Identification of risk factors in atypical chronic myeloid leukemia.
Massimo Breccia, Francesca Biondo, Roberto Latagliata, Ida Carmosino, Franco Mandelli, Giuliana Alimena. Haematologica 2006
57
45

Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
Carlo B Gambacorti-Passerini, Carla Donadoni, Andrea Parmiani, Alessandra Pirola, Sara Redaelli, Giovanni Signore, Vincenzo Piazza, Luca Malcovati, Diletta Fontana, Roberta Spinelli,[...]. Blood 2015
76
34

Somatic SETBP1 mutations in myeloid malignancies.
Hideki Makishima, Kenichi Yoshida, Nhu Nguyen, Bartlomiej Przychodzen, Masashi Sanada, Yusuke Okuno, Kwok Peng Ng, Kristbjorn O Gudmundsson, Bandana A Vishwakarma, Andres Jerez,[...]. Nat Genet 2013
171
23

Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Véronique Gelsi-Boyer, Manja Meggendorfer, Margot Morabito, Céline Berthon, Lionel Adès, Pierre Fenaux, Odile Beyne-Rauzy,[...]. J Clin Oncol 2013
337
21

Somatic mutations of calreticulin in myeloproliferative neoplasms.
Thorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, Harini Nivarthi, Elisa Rumi, Jelena D Milosevic, Nicole C C Them, Tiina Berg, Bettina Gisslinger, Daniela Pietra,[...]. N Engl J Med 2013
21

ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.
Michelle A Elliott, Animesh Pardanani, Curtis A Hanson, Terra L Lasho, Christy M Finke, Alem A Belachew, Ayalew Tefferi. Am J Hematol 2015
44
45

WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature.
M A Elliott, C A Hanson, G W Dewald, S A Smoley, T L Lasho, A Tefferi. Leukemia 2005
58
32

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
James W Vardiman, Jüergen Thiele, Daniel A Arber, Richard D Brunning, Michael J Borowitz, Anna Porwit, Nancy Lee Harris, Michelle M Le Beau, Eva Hellström-Lindberg, Ayalew Tefferi,[...]. Blood 2009
19

Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia.
J M Hernández, M C del Cañizo, A Cuneo, J L García, N C Gutiérrez, M González, G Castoldi, J F San Miguel. Ann Oncol 2000
71
23


SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).
Manja Meggendorfer, Andreas Roller, Torsten Haferlach, Christiane Eder, Frank Dicker, Vera Grossmann, Alexander Kohlmann, Tamara Alpermann, Kenichi Yoshida, Seishi Ogawa,[...]. Blood 2012
206
16

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
J Nangalia, C E Massie, E J Baxter, F L Nice, G Gundem, D C Wedge, E Avezov, J Li, K Kollmann, D G Kent,[...]. N Engl J Med 2013
16

CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.
Yajuan Cui, Bing Li, Robert Peter Gale, Qian Jiang, Zefeng Xu, Tiejun Qin, Peihong Zhang, Yue Zhang, Zhijian Xiao. J Hematol Oncol 2014
30
53

Genomics of chronic neutrophilic leukemia.
Julia E Maxson, Jeffrey W Tyner. Blood 2017
42
38


Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia.
M Koldehoff, D W Beelen, R Trenschel, N K Steckel, R Peceny, M Ditschkowski, H Ottinger, A H Elmaagacli. Bone Marrow Transplant 2004
30
46

Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.
Mrinal M Patnaik, Daniela Barraco, Terra L Lasho, Christy M Finke, Kaaren Reichard, Katherine P Hoversten, Rhett P Ketterling, Naseema Gangat, Ayalew Tefferi. Am J Hematol 2017
32
43

Frequent pathway mutations of splicing machinery in myelodysplasia.
Kenichi Yoshida, Masashi Sanada, Yuichi Shiraishi, Daniel Nowak, Yasunobu Nagata, Ryo Yamamoto, Yusuke Sato, Aiko Sato-Otsubo, Ayana Kon, Masao Nagasaki,[...]. Nature 2011
13

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.
M M Patnaik, R Itzykson, T L Lasho, O Kosmider, C M Finke, C A Hanson, R A Knudson, R P Ketterling, A Tefferi, E Solary. Leukemia 2014
164
13

Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.
Hirotoshi Sakaguchi, Yusuke Okuno, Hideki Muramatsu, Kenichi Yoshida, Yuichi Shiraishi, Mariko Takahashi, Ayana Kon, Masashi Sanada, Kenichi Chiba, Hiroko Tanaka,[...]. Nat Genet 2013
149
13

Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia.
Renée Beekman, Marijke G Valkhof, Mathijs A Sanders, Paulette M H van Strien, Jurgen R Haanstra, Lianne Broeders, Wendy M Geertsma-Kleinekoort, Anjo J P Veerman, Peter J M Valk, Roel G Verhaak,[...]. Blood 2012
116
13

An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.
Tariq I Mughal, Nicholas C P Cross, Eric Padron, Ramon V Tiu, Michael Savona, Luca Malcovati, Raoul Tibes, Rami S Komrokji, Jean-Jacques Kiladjian, Guillermo Garcia-Manero,[...]. Haematologica 2015
64
20

The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT.
S E Langabeer, S L McCarron, K Haslam, M T O'Donovan, E Conneally. Bone Marrow Transplant 2014
17
76

BCR rearrangement-negative chronic myelogenous leukemia revisited.
R Kurzrock, C E Bueso-Ramos, H Kantarjian, E Freireich, S L Tucker, M Siciliano, S Pilat, M Talpaz. J Clin Oncol 2001
48
27

Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.
Katerina Zoi, Nicholas C P Cross. Int J Hematol 2015
35
37

Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.
Emanuele Ammatuna, Matthias Eefting, Kirsten van Lom, François G Kavelaars, Peter J M Valk, Ivo P Touw. Ann Hematol 2015
24
54

What's different about atypical CML and chronic neutrophilic leukemia?
Kim-Hien T Dao, Jeffrey W Tyner. Hematology Am Soc Hematol Educ Program 2015
19
68

G-CSF and its receptor in myeloid malignancy.
Renée Beekman, Ivo P Touw. Blood 2010
104
12

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.
T Haferlach, Y Nagata, V Grossmann, Y Okuno, U Bacher, G Nagae, S Schnittger, M Sanada, A Kon, T Alpermann,[...]. Leukemia 2014
843
12

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.
Francis H Grand, Claire E Hidalgo-Curtis, Thomas Ernst, Katerina Zoi, Christine Zoi, Carolann McGuire, Sebastian Kreil, Amy Jones, Joannah Score, Georgia Metzgeroth,[...]. Blood 2009
290
12

SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia.
Ion Cristóbal, Francisco J Blanco, Laura Garcia-Orti, Nerea Marcotegui, Carmen Vicente, José Rifon, Francisco J Novo, Eva Bandres, María J Calasanz, Carmelo Bernabeu,[...]. Blood 2010
107
12

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia.
Esperanza Such, Ulrich Germing, Luca Malcovati, José Cervera, Andrea Kuendgen, Matteo G Della Porta, Benet Nomdedeu, Leonor Arenillas, Elisa Luño, Blanca Xicoy,[...]. Blood 2013
169
12

Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Francesco Onida, Greg Ball, Hagop M Kantarjian, Terry L Smith, Armand Glassman, Maher Albitar, Barbara Scappini, Mary Beth Rios, Michael J Keating, Miloslav Beran. Cancer 2002
45
26


The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
Julia E Maxson, Samuel B Luty, Jason D MacManiman, Jason C Paik, Jason Gotlib, Peter Greenberg, Swaleh Bahamadi, Samantha L Savage, Melissa L Abel, Christopher A Eide,[...]. Clin Cancer Res 2016
28
42

Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia.
Vishesh Khanna, Scott T Pierce, Kim-Hien T Dao, Cristina E Tognon, David E Hunt, Brian Junio, Jeffrey W Tyner, Brian J Druker. Cureus 2015
22
54

An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia.
Isabelle Plo, Yanyan Zhang, Jean-Pierre Le Couédic, Mayuka Nakatake, Jean-Michel Boulet, Miki Itaya, Steven O Smith, Najet Debili, Stefan N Constantinescu, William Vainchenker,[...]. J Exp Med 2009
52
21

Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases.
S J Corey, A L Burkhardt, J B Bolen, R L Geahlen, L S Tkatch, D J Tweardy. Proc Natl Acad Sci U S A 1994
198
11

Clinical and biological implications of driver mutations in myelodysplastic syndromes.
Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, Sudhir Tauro, Gunes Gundem, Peter Van Loo, Chris J Yoon, Peter Ellis, David C Wedge, Andrea Pellagatti,[...]. Blood 2013
11

SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
F Damm, R Itzykson, O Kosmider, N Droin, A Renneville, V Chesnais, V Gelsi-Boyer, S de Botton, N Vey, C Preudhomme,[...]. Leukemia 2013
86
12

Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.
J Broséus, T Alpermann, M Wulfert, L Florensa Brichs, S Jeromin, E Lippert, M Rozman, F Lifermann, V Grossmann, T Haferlach,[...]. Leukemia 2013
66
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.